Great Lakes Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,767
| Closed | -$210K | – | 878 |
|
|
2024
Q2 | $210K | Buy |
+1,767
| New | +$210K | ﹤0.01% | 797 |
|
|
2023
Q2 | – | Sell |
-3,129
| Closed | -$481K | – | 818 |
|
|
2023
Q1 | $481K | Sell |
3,129
-103
| -3% | -$15.8K | ﹤0.01% | 645 |
|
|
2022
Q4 | $581K | Buy |
3,232
+8
| +0.2% | +$1.44K | 0.03% | 484 |
|
|
2022
Q3 | $382K | Sell |
3,224
-17,876
| -85% | -$2.12M | 0.01% | 521 |
|
|
2022
Q2 | $3.01M | Buy |
21,100
+13,828
| +190% | +$1.98M | 0.06% | 307 |
|
|
2022
Q1 | $1.25M | Sell |
7,272
-31,467
| -81% | -$5.42M | 0.02% | 424 |
|
|
2021
Q4 | $9.84M | Sell |
38,739
-362
| -0.9% | -$91.9K | 0.15% | 179 |
|
|
2021
Q3 | $15M | Buy |
39,101
+7,926
| +25% | +$3.05M | 0.23% | 137 |
|
|
2021
Q2 | $7.33M | Sell |
31,175
-139
| -0.4% | -$32.7K | 0.11% | 224 |
|
|
2021
Q1 | $4.1M | Buy |
+31,314
| New | +$4.1M | 0.07% | 290 |
|